ENTEROBACTERIACEAE INFECTIONS
Clinical trials for ENTEROBACTERIACEAE INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new ENTEROBACTERIACEAE INFECTIONS trials appear
Sign up with your email to follow new studies for ENTEROBACTERIACEAE INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibiotic strategy aims to spare Last-Resort drugs for ICU lung infections
Disease control CompletedThis study looked at whether a common antibiotic, piperacillin-tazobactam, could be used instead of stronger last-resort antibiotics to treat lung infections in ICU patients on ventilators. The patients had resistant bacteria in their gut. The goal was to see if this approach cou…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 26, 2026 07:47 UTC
-
ICU superbug study reveals resistance patterns
Knowledge-focused CompletedThis study looked at 314 intensive care unit patients with bloodstream infections caused by Enterobacterales bacteria. Researchers wanted to understand how often these bacteria are resistant to common antibiotics and what factors make patients more likely to have a resistant infe…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Sponsor: Ankara City Hospital Bilkent • Aim: Knowledge-focused
Last updated May 26, 2026 07:43 UTC
-
Superbug strikes ICU during COVID crisis – Here's how they fought back
Knowledge-focused CompletedThis study looked at how a hospital intensive care unit (ICU) managed an outbreak of a hard-to-treat bacteria (VIM-producing Enterobacter cloacae) during the 2020 COVID-19 pandemic. Researchers reviewed the cases of 14 ICU patients who had this bacteria to understand what actions…
Matched conditions: ENTEROBACTERIACEAE INFECTIONS
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC